These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25751722)

  • 1. Identification and pharmacokinetics of multiple potential bioactive constituents after oral administration of radix astragali on cyclophosphamide-induced immunosuppression in Balb/c mice.
    Liu M; Li P; Zeng X; Wu H; Su W; He J
    Int J Mol Sci; 2015 Mar; 16(3):5047-71. PubMed ID: 25751722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of pharmacokinetic profiles and characteristics of active components and their metabolites in rat plasma following oral administration of the water extract of Astragali radix using UPLC-MS/MS.
    Shi J; Zheng L; Lin Z; Hou C; Liu W; Yan T; Zhu L; Wang Y; Lu L; Liu Z
    J Ethnopharmacol; 2015 Jul; 169():183-94. PubMed ID: 25917840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of calycosin-7-O-β-D-glucoside, ononin, calycosin, formononetin, astragaloside IV, and astragaloside II in rat plasma after oral administration of Radix Astragali extraction for their pharmacokinetic studies by ultra-pressure liquid chromatography with tandem mass spectrometry.
    Liu XH; Zhao JB; Guo L; Yang YL; Hu F; Zhu RJ; Feng SL
    Cell Biochem Biophys; 2014 Sep; 70(1):677-86. PubMed ID: 24782060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical profile- and pharmacokinetics-based investigation of the synergistic property of platycodonis radix in traditional Chinese medicine formula Shengxian decoction.
    Zhang F; Zhan Q; Gao S; Dong X; Jiang B; Sun L; Tao X; Chen WS
    J Ethnopharmacol; 2014 Mar; 152(3):497-507. PubMed ID: 24524880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption and metabolism of Astragali radix decoction: in silico, in vitro, and a case study in vivo.
    Xu F; Zhang Y; Xiao S; Lu X; Yang D; Yang X; Li C; Shang M; Tu P; Cai S
    Drug Metab Dispos; 2006 Jun; 34(6):913-24. PubMed ID: 16507649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution of six major bio-active components after oral administration of Zhenqi Fuzheng capsules to rats using ultra-pressure liquid chromatography-tandem mass spectrometry.
    Liu XH; Zhu RJ; Hu F; Guo L; Yang YL; Feng SL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():44-53. PubMed ID: 25706566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality evaluation for Radix Astragali based on fingerprint, indicative components selection and QAMS.
    Huang J; Yin L; Dong L; Quan H; Chen R; Hua S; Ma J; Guo D; Fu X
    Biomed Chromatogr; 2018 Nov; 32(11):e4343. PubMed ID: 30003570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC-MS/MS analysis of a traditional Chinese medical formulation of Bu-Yang-Huan-Wu-Tang and its pharmacokinetics after oral administration to rats.
    Shaw LH; Lin LC; Tsai TH
    PLoS One; 2012; 7(8):e43848. PubMed ID: 22952787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The profiling and identification of the absorbed constituents and metabolites of Paeoniae Radix Rubra decoction in rat plasma and urine by the HPLC-DAD-ESI-IT-TOF-MS(n) technique: a novel strategy for the systematic screening and identification of absorbed constituents and metabolites from traditional Chinese medicines.
    Liang J; Xu F; Zhang YZ; Huang S; Zang XY; Zhao X; Zhang L; Shang MY; Yang DH; Wang X; Cai SQ
    J Pharm Biomed Anal; 2013 Sep; 83():108-21. PubMed ID: 23727363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of three constituents in Radix Astragali by HPLC-MS].
    Li X; Zhu ZY; Wang B; Lou ZY; Chai YF
    Yao Xue Xue Bao; 2006 Aug; 41(8):793-6. PubMed ID: 17039790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic screening and characterization of Qi-Li-Qiang-Xin capsule-related xenobiotics in rats by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.
    Yun WJ; Yao ZH; Fan CL; Qin ZF; Tang XY; Gao MX; Dai Y; Yao XS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1090():56-64. PubMed ID: 29787993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling and identification of the metabolites of calycosin in rat hepatic 9000×g supernatant incubation system and the metabolites of calycosin-7-O-β-D-glucoside in rat urine by HPLC-DAD-ESI-IT-TOF-MS(n) technique.
    Zhang YZ; Xu F; Dong J; Liang J; Hashi Y; Shang MY; Yang DH; Wang X; Cai SQ
    J Pharm Biomed Anal; 2012 Nov; 70():425-39. PubMed ID: 22766358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of novel astragaloside malonates from Radix Astragali by HPLC with ESI quadrupole TOF MS.
    Chu C; Cai HX; Ren MT; Liu EH; Li B; Qi LW; Li P
    J Sep Sci; 2010 Mar; 33(4-5):570-81. PubMed ID: 20162633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the In Vivo Existence Forms (23 Original Constituents and 147 Metabolites) of Astragali Radix Total Flavonoids and Their Distributions in Rats Using HPLC-DAD-ESI-IT-TOF-MS
    Liu LJ; Li HF; Xu F; Wang HY; Zhang YF; Liu GX; Shang MY; Wang X; Cai SQ
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33256251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of high-performance liquid chromatography-electrospray ionization time-of-flight mass spectrometry for analysis and quality control of Radix Astragali and its preparations.
    Qi LW; Li P; Ren MT; Yu QT; Wen XD; Wang YX
    J Chromatogr A; 2009 Mar; 1216(11):2087-97. PubMed ID: 18353340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytochemical analysis of an antiviral fraction of Radix astragali using HPLC-DAD-ESI-MS/MS.
    Tang L; Liu Y; Wang Y; Long C
    J Nat Med; 2010 Apr; 64(2):182-6. PubMed ID: 20037801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive components on immuno-enhancement effects in the traditional Chinese medicine Shenqi Fuzheng Injection based on relevance analysis between chemical HPLC fingerprints and in vivo biological effects.
    Wang J; Tong X; Li P; Liu M; Peng W; Cao H; Su W
    J Ethnopharmacol; 2014 Aug; 155(1):405-15. PubMed ID: 24950446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of calycosin-7-O-beta-D-glucoside, ononin, astragaloside IV, astragaloside I and ferulic acid in rat plasma after oral administration of Danggui Buxue Tang extract for their pharmacokinetic studies by liquid chromatography-mass spectrometry.
    Wen XD; Qi LW; Li P; Bao KD; Yan XW; Yi L; Li CY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 865(1-2):99-105. PubMed ID: 18346946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using UPLC-MS/MS for Characterization of Active Components in Extracts of Yupingfeng and Application to a Comparative Pharmacokinetic Study in Rat Plasma after Oral Administration.
    Jia MQ; Xiong YJ; Xue Y; Wang Y; Yan C
    Molecules; 2017 May; 22(5):. PubMed ID: 28513568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and analysis of the multiple absorbed bioactive components and metabolites of Dangguibuxue decoction by the metabolic fingerprinting technique and liquid chromatography/diode-array detection mass spectrometry.
    Wang P; Liang Y; Zhou N; Chen B; Yi L; Yu Y; Yi Z
    Rapid Commun Mass Spectrom; 2007; 21(2):99-106. PubMed ID: 17154345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.